Genus plc (LON:GNS – Get Free Report) insider Jorgen Kokke sold 2,186 shares of the firm’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of GBX 1,956 ($25.84), for a total value of £42,758.16 ($56,483.70).
Genus Stock Down 2.9 %
LON GNS opened at GBX 1,900 ($25.10) on Wednesday. Genus plc has a 52 week low of GBX 1,478 ($19.52) and a 52 week high of GBX 2,378 ($31.41). The company has a quick ratio of 1.08, a current ratio of 1.80 and a debt-to-equity ratio of 53.54. The business’s fifty day simple moving average is GBX 1,771.67 and its 200-day simple moving average is GBX 1,773.76. The firm has a market cap of £1.25 billion, a PE ratio of 15,997.56, a P/E/G ratio of 2.87 and a beta of 0.37.
Genus Increases Dividend
The business also recently declared a dividend, which will be paid on Friday, December 6th. Stockholders of record on Thursday, November 7th will be issued a dividend of GBX 21.70 ($0.29) per share. This represents a dividend yield of 1.21%. The ex-dividend date is Thursday, November 7th. This is a positive change from Genus’s previous dividend of $10.30. Genus’s payout ratio is currently 26,666.67%.
Wall Street Analyst Weigh In
Get Our Latest Stock Report on GNS
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Further Reading
- Five stocks we like better than Genus
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- How to invest in marijuana stocks in 7 steps
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- What is Short Interest? How to Use It
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.